Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Silveira, DRA"'
Autor:
Lindijane de Souza Bento Almeida, Dra., Christiana Soares de Freitas, Dra., Doriana Daroit, Dra., Raquel Maria da Costa Silveira, Dra., Ana Vitória Araújo Fernandes, Mtra.
Publikováno v:
GIGAPP Estudios Working Papers, Vol 10, Iss 248-255 (2023)
O artigo apresenta e discute resultados de pesquisa realizada a partir da análise de 204 inovações democráticas na área de saúde identificadas na América Latina e Caribe. O objetivo principal foi analisar as suas repercussões efetivas em proc
Externí odkaz:
https://doaj.org/article/7a47aaccb9d8401f866a67d100f6f2c2
Autor:
Mendes FR; Division of Hematology, Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo, Av. Dr. Arnaldo, 251, Cerqueira César, São Paulo, CEP 01246-000, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil., da Silva WF; Division of Hematology, Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo, Av. Dr. Arnaldo, 251, Cerqueira César, São Paulo, CEP 01246-000, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil., da Costa Bandeira de Melo R; Division of Hematology, Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo, Av. Dr. Arnaldo, 251, Cerqueira César, São Paulo, CEP 01246-000, Brazil.; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, São Paulo, Brazil., Silveira DRA; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil.; Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, SE5 8AF, UK., Velloso EDRP; Division of Hematology, Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo, Av. Dr. Arnaldo, 251, Cerqueira César, São Paulo, CEP 01246-000, Brazil.; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, São Paulo, Brazil., Rocha V; Division of Hematology, Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo, Av. Dr. Arnaldo, 251, Cerqueira César, São Paulo, CEP 01246-000, Brazil.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil.; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, São Paulo, Brazil., Rego EM; Division of Hematology, Instituto do Cancer do Estado de São Paulo (ICESP), Faculdade de Medicina da Universidade de Sao Paulo, Av. Dr. Arnaldo, 251, Cerqueira César, São Paulo, CEP 01246-000, Brazil. eduardo.rego@fm.usp.br.; Laboratory of Medical Investigation in Pathogenesis and Targeted Therapy in Onco-Immuno-Hematology (LIM-31), Department of Hematology, Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, São Paulo, Brazil. eduardo.rego@fm.usp.br.; Division of Hematology, Hospital das Clinicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, São Paulo, Brazil. eduardo.rego@fm.usp.br.
Publikováno v:
Annals of hematology [Ann Hematol] 2022 Jan; Vol. 101 (1), pp. 147-154. Date of Electronic Publication: 2021 Oct 21.
Autor:
Weinhäuser I; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Pereira-Martins DA; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Almeida LY; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Hilberink JR; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Silveira DRA; Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, SE5 8AF, UK., Quek L; Myeloid Leukaemia Genomics and Biology Group, School of Cancer and Pharmaceutical Sciences, King's College London, London, SE5 8AF, UK., Ortiz C; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil.; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Araujo CL; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Bianco TM; Department of Internal Medicine, Medical School of Ribeirao Preto, University of São Paulo, Ribeirao Preto, Brazil., Lucena-Araujo A; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Mota JM; Medical Oncology Service, Sao Paulo State Cancer Institute, University of Sao Paulo, Brazil., Hogeling SM; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Sternadt D; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Visser N; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Diepstra A; Department of Pathology and Medical Biology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Ammatuna E; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Huls G; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands., Rego EM; Center for Cell Based Therapy, University of São Paulo, Ribeirao Preto, Brazil., Schuringa JJ; Department of Experimental Hematology, Cancer Research Centre Groningen, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.
Publikováno v:
Science advances [Sci Adv] 2023 Apr 14; Vol. 9 (15), pp. eadf8522. Date of Electronic Publication: 2023 Apr 14.
Publikováno v:
In Hematology, Transfusion and Cell Therapy October 2021 43 Supplement 1:S150-S150
Autor:
Coelho-Silva JL; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil.; Center for Cell-Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Silveira DRA; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, SP, Brazil.; Department of Haematology, AC Camargo Cancer Centre, Sao Paulo, Brazil., Pereira-Martins DA; Center for Cell-Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.; Department of Internal Medicine, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil., Rojas CAO; Center for Cell-Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil., Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Rego EM; Center for Cell-Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil.; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, SP, Brazil., Machado-Neto JA; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., Bendit I; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, SP, Brazil., Rocha V; Hematology Division, LIM31, Faculdade de Medicina, University of São Paulo, São Paulo, SP, Brazil., Traina F; Department of Medical Imaging, Haematology, and Oncology, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, SP, Brazil. ftraina@fmrp.usp.br.; Center for Cell-Based Therapy, São Paulo Research Foundation, Ribeirão Preto, SP, Brazil. ftraina@fmrp.usp.br.
Publikováno v:
Scientific reports [Sci Rep] 2021 Jan 18; Vol. 11 (1), pp. 1675. Date of Electronic Publication: 2021 Jan 18.
Autor:
Silveira DRA; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil.; Department of Hematology, AC Camargo Cancer Center, Sao Paulo, Brazil., Coelho-Silva JL; Department of Medical Images, Hematology and Clinical Oncology, University of Sao Paulo at Ribeirao Preto Medical School (FMRP), Ribeirao Preto, Brazil., Silva WF; Leukemia Unit, Cancer Institute of Sao Paulo (ICESP), University of Sao Paulo Medical School, Sao Paulo, Brazil., Vallance G; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Pereira-Martins DA; Department of Medical Images, Hematology and Clinical Oncology, University of Sao Paulo at Ribeirao Preto Medical School (FMRP), Ribeirao Preto, Brazil., Madeira MIA; Department of Medical Images, Hematology and Clinical Oncology, University of Sao Paulo at Ribeirao Preto Medical School (FMRP), Ribeirao Preto, Brazil., Figueredo-Pontes LL; Department of Medical Images, Hematology and Clinical Oncology, University of Sao Paulo at Ribeirao Preto Medical School (FMRP), Ribeirao Preto, Brazil., Velloso EDRP; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil.; Leukemia Unit, Cancer Institute of Sao Paulo (ICESP), University of Sao Paulo Medical School, Sao Paulo, Brazil., Simões BP; Department of Medical Images, Hematology and Clinical Oncology, University of Sao Paulo at Ribeirao Preto Medical School (FMRP), Ribeirao Preto, Brazil., Peniket A; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Danby R; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Rego EM; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil.; Leukemia Unit, Cancer Institute of Sao Paulo (ICESP), University of Sao Paulo Medical School, Sao Paulo, Brazil., Vyas P; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; MRC MHU, BRC Haematology Theme, Oxford Biomedical Research Center, Oxford Center for Hematology, WIMM, Radcliffe Department of Medicine, University of Oxford, Oxford, UK., Traina F; Department of Medical Images, Hematology and Clinical Oncology, University of Sao Paulo at Ribeirao Preto Medical School (FMRP), Ribeirao Preto, Brazil., Bendit I; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil., Quek L; Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, UK., Rocha V; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology (LIM-31) HCFMUSP, University of Sao Paulo Medical School, Sao Paulo, Brazil.; Leukemia Unit, Cancer Institute of Sao Paulo (ICESP), University of Sao Paulo Medical School, Sao Paulo, Brazil.; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Jan; Vol. 62 (1), pp. 147-157. Date of Electronic Publication: 2020 Sep 30.
Autor:
Thomé CH; Department of Biochemistry and Immunology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Ferreira GA; Department of Biochemistry and Immunology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Pereira-Martins DA; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Dos Santos GA; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Ortiz CA; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., de Souza LEB; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Sobral LM; Department of Clinical Analyses, Toxicology and Food Sciences, University of São Paulo, Ribeirão Preto, Brazil., Silva CLA; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Scheucher PS; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Gil CD; Department of Morphology and Genetics, Federal University of São Paulo, São Paulo, Brazil., Leopoldino AM; Department of Clinical Analyses, Toxicology and Food Sciences, University of São Paulo, Ribeirão Preto, Brazil., Silveira DRA; Hematology, Medical School, University of São Paulo, São Paulo, Brazil., Coelho-Silva JL; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Traina F; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Koury LC; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Melo RAM; Department of Internal Medicine, University of Pernambuco, Recife, Brazil., Bittencourt R; Hematology Division, Federal University of Rio Grande do Sul, Porto Alegre, Brazil., Pagnano K; Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil., Pasquini R; Hematology Division, Federal University of Paraná, Curitiba, Brazil., Nunes EC; Hematology Division, Federal University of Paraná, Curitiba, Brazil., Fagundes EM; Hematology Division, Federal University of Minas Gerais, Belo Horizonte, Brazil., Gloria ABF; Hematology Division, Federal University of Minas Gerais, Belo Horizonte, Brazil., Kerbauy FR; Federal University of São Paulo, São Paulo, Brazil., Chauffaille ML; Federal University of São Paulo, São Paulo, Brazil., Keating A; Cell Therapy Program, Princess Margaret Cancer Centre, Toronto, Canada., Tallman MS; Leukemia Service, Memorial Sloan-Kettering Cancer Center/Weill Cornell Medical College, New York, USA., Ribeiro RC; Department of Oncology, St. Jude Children's Research Hospital, Memphis, USA., Dillon R; Department of Medical and Molecular Genetics, King's College London School of Medicine, London, UK., Ganser A; Department of Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany., Löwenberg B; Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands., Valk P; Santa Lucia Foundation, Rome, Italy., Lo-Coco F; Department of Biopathology, Tor Vergata University, Rome, Italy.; Santa Lucia Foundation, Rome, Italy., Sanz MA; Department of Hematology, Valencia University Medical School, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Berliner N; Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, USA., Faça VM; Department of Biochemistry and Immunology, Medical School of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil., Rego EM; Regional Blood Center of Ribeirão Preto, Medical School of Ribeirão Preto, Center for Cell Based Therapy, University of São Paulo, Ribeirão Preto, Brazil. eduardo.rego@fm.usp.br.; LIM31, Hematology, Medical School, University of São Paulo, São Paulo, Brazil. eduardo.rego@fm.usp.br.
Publikováno v:
Scientific reports [Sci Rep] 2020 Jun 25; Vol. 10 (1), pp. 10315. Date of Electronic Publication: 2020 Jun 25.
Autor:
Silveira DRA; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil.; Department of Hematology, AC Camargo Cancer Center, São Paulo, Brazil., Quek L; Medical Research Council MHU, BRC Hematology Theme, Oxford Biomedical Research Center, Oxford Center for Hematology, WIMM, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Santos IS; Internal Medicine Department, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil., Corby A; Medical Research Council MHU, BRC Hematology Theme, Oxford Biomedical Research Center, Oxford Center for Hematology, WIMM, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Coelho-Silva JL; Department of Medical Images, Hematology and Clinical Oncology, University of São Paulo at Ribeirao Preto Medical School, Ribeirao Preto, Brazil., Pereira-Martins DA; Department of Medical Images, Hematology and Clinical Oncology, University of São Paulo at Ribeirao Preto Medical School, Ribeirao Preto, Brazil., Vallance G; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Brown B; Medical Research Council MHU, BRC Hematology Theme, Oxford Biomedical Research Center, Oxford Center for Hematology, WIMM, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Nardinelli L; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil., Silva WF; Leukemia Unit, Cancer Institute of São Paulo, University of São Paulo Medical School, São Paulo, Brazil; and., Velloso EDRP; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil.; Leukemia Unit, Cancer Institute of São Paulo, University of São Paulo Medical School, São Paulo, Brazil; and., Lucena-Araujo AR; Department of Genetics, Federal University of Pernambuco, Recife, Brazil., Traina F; Department of Medical Images, Hematology and Clinical Oncology, University of São Paulo at Ribeirao Preto Medical School, Ribeirao Preto, Brazil., Peniket A; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Vyas P; Medical Research Council MHU, BRC Hematology Theme, Oxford Biomedical Research Center, Oxford Center for Hematology, WIMM, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Rego EM; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil.; Leukemia Unit, Cancer Institute of São Paulo, University of São Paulo Medical School, São Paulo, Brazil; and., Bendit I; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil., Rocha V; Service of Hematology, Transfusion and Cell Therapy and Laboratory of Medical Investigation in Pathogenesis and Directed Therapy in Onco-Immuno-Hematology, HCFMUSP, University of São Paulo Medical School, São Paulo, Brazil.; Department of Hematology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.; Leukemia Unit, Cancer Institute of São Paulo, University of São Paulo Medical School, São Paulo, Brazil; and.
Publikováno v:
Blood advances [Blood Adv] 2020 May 26; Vol. 4 (10), pp. 2339-2350.
Autor:
Silva WFD; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Rosa LID; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Seguro FS; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Silveira DRA; Hematologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Bendit I; Hematologia, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Buccheri V; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Velloso EDRP; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Rocha V; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR., Rego EM; Instituto do Cancer do Estado de Sao Paulo (ICESP), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR.
Publikováno v:
Clinics (Sao Paulo, Brazil) [Clinics (Sao Paulo)] 2020 Apr 06; Vol. 75, pp. e1566. Date of Electronic Publication: 2020 Apr 06 (Print Publication: 2020).
Autor:
Silva WFD Jr; Institute of Cancer of São Paulo, University of São Paulo, São Paulo, Brazil. Electronic address: wellington.fernandes@hc.fm.usp.br., Rosa LID; Institute of Cancer of São Paulo, University of São Paulo, São Paulo, Brazil., Marquez GL; Institute of Cancer of São Paulo, University of São Paulo, São Paulo, Brazil., Bassolli L; Hospital das Clinicas, University of São Paulo, São Paulo, Brazil., Tucunduva L; Hospital das Clinicas, University of São Paulo, São Paulo, Brazil., Silveira DRA; Hospital das Clinicas, University of São Paulo, São Paulo, Brazil., Buccheri V; Institute of Cancer of São Paulo, University of São Paulo, São Paulo, Brazil; Hospital das Clinicas, University of São Paulo, São Paulo, Brazil., Bendit I; Hospital das Clinicas, University of São Paulo, São Paulo, Brazil., Rego EM; Institute of Cancer of São Paulo, University of São Paulo, São Paulo, Brazil; Hospital das Clinicas, University of São Paulo, São Paulo, Brazil., Rocha V; Institute of Cancer of São Paulo, University of São Paulo, São Paulo, Brazil; Hospital das Clinicas, University of São Paulo, São Paulo, Brazil., Velloso EDRP; Institute of Cancer of São Paulo, University of São Paulo, São Paulo, Brazil; Hospital das Clinicas, University of São Paulo, São Paulo, Brazil.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2019 Feb; Vol. 19 (2), pp. e116-e122. Date of Electronic Publication: 2018 Nov 12.